key: cord-0977632-4l0g7shk
authors: Roy, Justin
title: Letter to the Editor
date: 2020-06-07
journal: J Card Fail
DOI: 10.1016/j.cardfail.2020.06.002
sha: c2ef2895b7d92cd59a23e4778646abcda3d7a563
doc_id: 977632
cord_uid: 4l0g7shk

nan

To the Editor:

We read with great interest the case report by Dr. Singh and colleagues describing a case of complicated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient with a left ventricular assist device (LVAD) [1] . They reported the patient's clinical course was complicated by septic shock in the setting of Escherichia coli and Lactobacillus species bacteremia, as well as acute acalculous cholecystitis (AAC) with the requirement for percutaneous cholecystectomy. However, in patients with LVAD, understanding the etiology of AAC primarily due to SARS-CoV-2 may have significant clinical implications.

The cause of AAC that required a percutaneous cholecystostomy tube may be related to septic shock. Still, consideration should be given to alternative etiologies. While AAC is a well-known occurrence in critically ill patients, its pathogenesis is thought to be due to gallbladder ischemia or bile stasis. It is commonly associated with shock, sepsis, and immunocompromised state [2] . Viral illnesses, including human immunodeficiency virus (HIV) and hepatitis B virus (HBV), have been implicated in AAC [2] . SARS-CoV-2 has been associated with vascular inflammation, possibly promoting ischemic gallbladder changes independent of the development of shock [3] . Finally, SARS-CoV-2 cellular entry is mediated by the angiotensin-converting enzyme 2 (ACE-2) receptor, which expresses in relatively high amounts in the liver and gallbladder, as well as in vascular endothelium [4] [5] . Patients with SARS-CoV-2 may be at increased risk not only from ischemic changes to the gallbladder because of a critical illness, but direct viral effects on the vascular endothelium and infection to the biliary tissue itself. Therefore, it is crucial to learn if any studies on the biliary aspirates were performed, including bile COVID-19 RT-PCR (reverse transcriptase-polymerase chain reaction) and bile culture, to confirm the presence of SARS-CoV-2 or coinfection with bacteria respectively. It is even possible that the gallbladder endothelium may be a potential reservoir for viral infection, given the high level of expression of ACE-2 receptors [4] . Follow-up bile testing if the patient continues to have percutaneous biliary drainage or gallbladder imaging may support COVID-19 recovery from an AAC standpoint.

Overall, clinicians treating patients with SARS-CoV-2 in the setting of LVAD with their multiple comorbidities should maintain a high clinical suspicion for the development of AAC. If the gallbladder is harboring prolonged viral replication, this may have clinical consequences, especially in LVAD patients being considered for a transplant. Current Centers for Disease Control (CDC) recommendations are for two consecutive nasopharyngeal RT-PCR test negatives (test-based strategy) to confirm COVID-19 disease recovery. Perhaps additional testing (including bile testing) or imaging should be done first in patients with LVAD and AAC to confirm recovery, especially prior to transplant.

Novel coronavirus disease 2019 in a patient on durable left ventricular assist device support

Acute acalculous cholecystitis: a review

Potential effects of coronavirus on the cardiovascular system: a review

A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis